androgen independent prostate cancer
Showing 1 - 25 of >10,000
Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,
Not yet recruiting
- Androgen-Independent Prostatic Cancer
- +8 more
- lorigerlimab
- +2 more
- (no location specified)
May 4, 2023
Prostate Cancer Trial in Philadelphia (docetaxel, sorafenib tosylate)
Completed
- Prostate Cancer
- docetaxel
- sorafenib tosylate
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Feb 16, 2022
Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in
Recruiting
- Castration-Resistant Prostatic Cancer
- +4 more
- ARAT
- +2 more
-
Orange City, Florida
- +1 more
Nov 23, 2022
Prostate Cancer Trial in Argentina, United States (Sagopilone (ZK 219477) + prednisone)
Completed
- Prostate Cancer
- Sagopilone (ZK 219477) + prednisone
-
Fountain Valley, California
- +16 more
Apr 6, 2021
Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)
Not yet recruiting
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- [177Lu]Lu-PSMA-617
- +3 more
- (no location specified)
Jan 23, 2023
Prostate Cancer, Malignant Tumor of Prostate, Secondary Malignant Tumor of Prostate Trial in Cleveland (drug, other, radiation)
Not yet recruiting
- Prostate Cancer
- +2 more
- Androgen deprivation therapy (ADT)
- +3 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center Seidman Cancer Cen
Nov 21, 2023
Prostate Cancer Trial in Cincinnati (Apalutamide Oral Product, Androgen Deprivation Therapy (ADT), Focal Therapy)
Not yet recruiting
- Prostate Cancer
- Apalutamide Oral Product
- +2 more
-
Cincinnati, OhioUniversity of Cincinnati Medical Center
Mar 27, 2023
Radiotherapy and Androgen Deprivation In Combination After Local
Not yet recruiting
- Prostate Cancer
- Luteinising Hormone-Releasing Factor Analogue
- (no location specified)
Nov 16, 2023
Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Leuven (Radiotherapy (SBRT) and/or surgery
Recruiting
- Prostate Cancer
- +6 more
- Radiotherapy (SBRT) and/or surgery (metastasectomy)
- +2 more
-
Leuven, BelgiumUniversity Hospitals Leuven
Jun 7, 2022
Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
- Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 4, 2023
Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Testosterone Cypionate
- Sipuleucel-T
-
New Haven, ConnecticutYale Cancer Center
Oct 20, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)
Active, not recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 12, 2023
Prostate Cancer Trial in Atlanta (Genistein, Placebo)
Adenocarcinoma of the Prostate Trial in Washington, Baltimore, Bethesda (Radiation Therapy, Androgen Deprivation Therapy (ADT))
Active, not recruiting
- Adenocarcinoma of the Prostate
- Radiation Therapy
- Androgen Deprivation Therapy (ADT)
-
Washington, District of Columbia
- +2 more
Oct 25, 2022
Androgen Metabolism, Metabolic Disease and Skeletal Muscle
Not yet recruiting
- Hypogonadism, Male
- +10 more
-
Dublin 9, IrelandBeaumont Hospital
Mar 16, 2023
Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor
Not yet recruiting
- Androgen Deprivation Therapy
- +4 more
- Gonadotropin-Releasing Hormone Agonist
- +2 more
- (no location specified)
Jan 18, 2023
Prostate Cancer Trial in San Francisco (STAND-T platform, Survey Administration, Text Messages)
Recruiting
- Prostate Cancer
- STAND-T platform
- +2 more
-
San Francisco, California
- +1 more
Oct 26, 2022
Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,
Recruiting
- Prostate Carcinoma
- +6 more
- Abiraterone Acetate
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Metastatic Hormone Sensitive Prostate Cancer Trial in China (Enzalutamide, Placebo, Androgen deprivation therapy (ADT))
Active, not recruiting
- Metastatic Hormone Sensitive Prostate Cancer
- Enzalutamide
- +2 more
-
Beijing, China
- +29 more
Jan 7, 2023
Androgen Deprivation Therapy, Prostate Cancer, Prostate Cancer Metastatic Trial in Boston (Aerobic and resistance exercise,
Recruiting
- Androgen Deprivation Therapy
- +2 more
- Aerobic and resistance exercise
- Usual Care
-
Boston, MassachusettsDana Farber Cancer Institute
Oct 4, 2022
Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in San Francisco (Ipilimumab, Laboratory Biomarker
Completed
- Recurrent Prostate Carcinoma
- Stage IV Prostate Cancer AJCC v7
- Ipilimumab
- +3 more
-
San Francisco, CaliforniaUCSF Medical Center-Mount Zion
Jul 29, 2020
Prospective Androgen Receptor Signaling Inhibitors Resistance
Not yet recruiting
- Prostate Cancer
- +3 more
- (no location specified)
Nov 15, 2023
Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel Trial in Nanjing (Docetaxel injection, Triptorelin Pamoate for
Active, not recruiting
- Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
- Docetaxel injection
- +2 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 24, 2022
Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)
Recruiting
- Prostate Cancer
- Prostate Disease
- Nivolumab
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 11, 2022